New NICE guideline on acute stroke and TIA: Need for major changes in delivery of stroke treatment

Heart

Volumn 95, Issue 10, 2009, Pages 841-843

  Werring, D J ^a   Brown, M M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; DIPYRIDAMOLE;

ACUTE DISEASE; ARTICLE; BLOOD CLOT LYSIS; BRAIN EDEMA; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HUMAN; LOW DRUG DOSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE DRUG DOSE; STROKE; TRANSIENT ISCHEMIC ATTACK;

GREAT BRITAIN; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINES AS TOPIC; STROKE; THROMBOLYTIC THERAPY;

EID: 66149144352     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.167676     Document Type: Article

References (13)

1. National Institute for Health and Clinical Excellence. Stroke: the diagnosis and initial management of acute stroke and transient ischaemic attack. 2008 (Clinical guideline 68). http://www.nice.org.uk/CG68 (accessed 13 Mar 2009).
2. Department of Health. National stroke strategy. London: DoH, 2007.
3. National Institute for Health and Clinical Excellence. Alteplase for the treatment of acute ischemic stroke (Technology appraisal 122). London: National Institute for Health and Clinical Excellence, 2007
4. National Audit Office. Reducing brain damage; faster access to better stroke care (HC 452 session 2005-6). London: National Audit Office, 2005.
5. Intercollegiate Stroke Working Party. National clinical guidelines for stroke. 3rd edn. London: Royal College of Physicians of London, 2008.
6. Nor AM, McAllister C, Louw SJ, et al. Agreement between ambulance paramedic- and physician-recorded neurological signs with face arm speech test (FAST) in acute stroke patients. Stroke 2004;35:1355-1359 (Pubitemid 38697457)
7. Nor AM, Davis J, Sen B, et al. The recognition of stroke in the emergency room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol 2005;4:727-734 (Pubitemid 41457288)
8. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369:283-292 (Pubitemid 46136488)
9. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370:1432-1442 (Pubitemid 47576154)
10. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6:215-222 (Pubitemid 46237760)
11. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. ISTCollaborative Group. Lancet 1997;349:1569-1581
12. CAST Collaborative Group. Chinese Acute Stroke Trial (CAST): randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-1649 (Pubitemid 27234805)
13. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke. New Engl J Med 2008;359:1317-1329